查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
尿液分析市場 - 全球行業規模、佔有率、趨勢、競爭、機遇和預測，2018-2028 年。按產品、按測試類型、按應用、按最終用戶、按地區和競爭細分
市場調查報告書
商品編碼
1326509

尿液分析市場 - 全球行業規模、佔有率、趨勢、競爭、機遇和預測，2018-2028 年。按產品、按測試類型、按應用、按最終用戶、按地區和競爭細分

Urinalysis Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028. Segmented By Product, By Test Type, By Application, By End user, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計尿液分析市場在 2024-2028 年的預測期內將以令人印象深刻的年複合成長率成長。這可歸因於糖尿病、腎病等慢性疾病患病率上升等因素。

慢性病患病率上升

糖尿病等慢性病患病率在全球範圍內不斷上升，引起了世界各地人口的巨大健康問題；例如，根據《國家糖尿病統計報告》，2020 年，大約有 3420 萬人年齡在 18 歲以下。以上均患有糖尿病。此外，由於血壓和血糖持續升高，大約三分之一的人口患有某種腎臟併發症。久坐的生活方式，包括食用不健康食品、飲酒、加工食品攝入量增加、缺乏運動等，正在導致世界各地糖尿病患病率不斷上升。為了確定糖尿病患者的血糖水平或確認個體是否患有糖尿病，尿液分析是一個重要的步驟，並且在全球範圍內經常進行。

尿路感染 (UTI) 的負擔日益加重

尿液分析是識別尿路感染 (UTI) 的常用診斷程序。診斷程序通過檢測和識別細胞、細菌、病毒、蛋白質、肌酐和濃度異常的物質來檢查尿液。尿路感染最常見的原因是細菌通過尿道進入尿道並開始在膀胱中繁殖。最常見的尿液感染類型是膀胱感染（膀胱炎）。可用於診斷腎臟感染（多腎炎）。常見尿路感染的風險上升可能是由於既往尿路感染、懷孕、年齡（老年人尿路感染患病率增加）、更年期、衛生條件差等造成的，這反過來又支持了預計將推動的市場成長。預測期。

家用尿液檢測套件的普及

家用尿液檢測套件可用於在家檢測是否存在尿路感染。尿路感染檢測試劑盒通常用作妊娠檢測試劑盒，在家幾分鐘內即可表明是否存在泌尿道感染。此外，這些檢測試劑盒對於檢測尿路感染的複發非常有幫助，從而採取進一步措施治愈它。此外，這些檢測試劑盒還提供家庭尿液藥物檢測篩查，並且 100% 隱私。試劑盒旨在診斷大麻、可卡因、甲基苯丙胺等。該尿液藥物檢測試劑盒可用於家庭測試，適用於家庭藥物測試、工作場所測試、學校、​​學院和大學藥物測試、執法測試、嚴重藥物濫用測試等

近期發展

2021 年 11 月，健康和營養指導初創公司 Vivoo 籌集了 600 萬美元的投資，用於創建提供飲食和生活方式建議的家庭尿液檢測。中低收入國家正在投資這些價格低廉但功能相似的分析儀。

可用的客製化

利用給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 覆蓋市場。
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球尿液分析市場展望。

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品（消耗品和儀器）
    • 按測試類型（妊娠和生育力測試、生化尿液分析和沈淀物尿液分析）
    • 按應用（疾病篩查和懷孕與生育）
    • 按最終用戶（診斷實驗室、醫院和診所、家庭護理機構以及研究實驗室和研究所）
    • 按公司分類 (2022)
    • 按地區
  • 產品市場地圖

第 6 章：亞太地區尿液分析市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 產品
    • 測試類型
    • 應用
    • 最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國 。
    • 印度 。
    • 韓國
    • 日本
    • 澳大利亞

第 7 章：歐洲尿液分析市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 產品
    • 測試類型
    • 應用
    • 最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：北美尿液分析市場展望。

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 產品
    • 測試類型
    • 應用
    • 最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國尿液分析市場展望
      • 市場規模及預測
        • 按價值
      • 市場佔有率及預測
        • 產品
        • 測試類型
        • 應用
        • 最終用戶
    • 墨西哥尿液分析市場展望
      • 市場規模及預測
        • 按價值
      • 市場佔有率及預測
        • 產品
        • 測試類型
        • 應用
        • 最終用戶
    • 加拿大尿液分析市場展望
      • 市場規模及預測
        • 按價值
      • 市場佔有率及預測
        • 產品
        • 測試類型
        • 應用
        • 最終用戶

第 9 章：南美尿液分析市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 類型
    • 產品類別
    • 組織
    • 最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲尿液分析市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 產品
    • 測試類型
    • 應用
    • 最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非 尿液分析
    • 沙烏地阿拉伯 尿液分析
    • 阿拉伯聯合大公國尿液分析
    • 科威特尿液分析

第 11 章：市場動態

  • 司機
  • 挑戰

第 12 章：市場趨勢與發展

  • 最近的發展
  • 併購
  • 產品開發

第13章：競爭格局

  • 商業概覽
  • 公司概況
  • 產品與服務
  • 財務（上市公司）
  • 最近的發展
  • SWOT分析
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers AG.
    • Abbott Laboratories
    • Cardinal Health Inc.
    • Danaher Corporation
    • Sysmex Corporation
    • Quidel Corporation
    • Becton, Dickinson & Company
    • Bio-Rad Laboratories Inc.
    • EKF Diagnostic s Holdings plc

第 14 章：戰略建議

簡介目錄
Product Code: 15094

Urinalysis Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing chronic disease prevalence, such as diabetes, kidney disease, etc.

Urinalysis is a test that examines the visual, chemical, and microscopic characteristics of urine. This test is utilized to detect and manage syndromes of diseases, such as kidney disease, urinary tract infections, and diabetes. Further, urinalysis being informative and a non-invasive diagnostic method for the identification of kidney disease propels the market demand for urinalysis and adds to the market growth.

Moreover, rising awareness of kidney and urinary tract infections among the population and increasing government initiatives, along with growing healthcare investments for the identification and management of the growing burden of kidney diseases, are some factors adding to the market growth and is anticipated to bolster the Global Urinalysis Market in the forecast period.

Rising Prevalence of Chronic Diseases

Rising chronic disease prevalence such as diabetes is increasing worldwide, causing a huge health concern among the population around the world; for instance, according to the National Diabetes Statistical Report, in 2020, approximately 34.2 million people aged 18 yrs. And above were affected with diabetes. Also, around one-third of the population was suffering some kind of kidney complication due to constant elevated blood pressure and blood sugar. The sedentary lifestyle, including consumption of unhealthy foods, alcohol consumption, increased processed food intake, lack of exercise, etc., is leading to the rising prevalence of diabetes around the world. To identify the glucose level in diabetic people or to confirm the diabetes occurrence in an individual, urinalysis is an important step and is frequently performed across the globe.

Growing Burden of Urinary Tract Infections (UTIs)

Urinalysis is a commonly utilized diagnostic procedure in the identification of a Urinary Tract infection (UTI). The diagnostic procedure examines the urine by detecting and identifying cells, bacteria, viruses, proteins, creatinine, and substances present in abnormal concentration. The most common cause of UTIs is when bacteria enter the urinary tract via the urethra and start flourishing in the bladder. The most common type of urine infection is bladder infection (cystitis). It can be used for the diagnosis of kidney infection (polynephritis). The rising risk of commonly observed UTI can be due to a previous UTI, pregnancy, age (older adults have increased UTI prevalence), menopause, poor hygiene, etc., and this is, in turn, supporting the market growth anticipated to boost in the forecast period.

The popularity of at-home Urine Testing Kits

At-home urine test kits are available for testing the presence of urinary tract infections at home. The UTI test kits commonly work as pregnancy test kits, which indicate the presence of a urinary infection in a few minutes at home. Also, these test kits are highly beneficial for testing the reoccurrence of a urinary tract infection, thereby taking further measures to get it cured. Furthermore, these test kits provide at-home screening for urine drug tests with 100% privacy. Kits are designed to diagnose marijuana, cocaine, methamphetamines, etc. This urine drug test kit is available for home-based tests suitable for home drug testing, workplace testing, school, college, and university drug testing, law enforcement testing, substantial drug abuse testing, etc.

Recent Development

In November 2021, Vivoo- a wellness and nutrition guidance startup, raised $6 million in investment for the creation of at-home urine testing that offers dietary and lifestyle advice. Middle-low-income countries are investing in these inexpensive but similarly functional analyzers.

Market Segmentation

Global Urinalysis Market is segmented based on the product, test type, application, end-user, and region. Based on the product, the market is segmented into consumables and instruments. Based on the test type, the market is segmented into pregnancy & fertility tests, biochemical urinalysis, and sediment urinalysis. Based on application, the market is fragmented into disease screening and pregnancy & fertility. Depending on the end user, the market is segmented into diagnostic laboratories, hospitals & clinics, home care settings, and research laboratories & institutes. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

F. Hoffmann-La Roche Ltd., Siemens Healthineers AG., Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, Sysmex Corporation, Quidel Coorporation, Becton, Dickinson & Company, Bio-Rad Laboratories Inc., EKF Diagnostic s Holdings plc, etc.., are some of the major players operating in the global Urinalysis Market.

Report Scope

In this report, Global Urinalysis Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Urinalysis Market, By Product:

  • Consumables
  • Instruments

Urinalysis Market, By Test Type:

  • Pregnancy & Fertility Tests
  • Biochemical Urinalysis
  • Sediment Urinalysis

Urinalysis Market, By Application:

  • Disease Screening
  • Pregnancy & Fertility

Urinalysis Market, By End User:

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Home Care Settings
  • Research Laboratories & Institutes

Urinalysis Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Urinalysis Market.

Available Customizations

With the given Marketdata, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Urinalysis Market Outlook.

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables & Instruments)
    • 5.2.2. By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis)
    • 5.2.3. By Application (Disease Screening and Pregnancy & Fertility)
    • 5.2.4. By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes)
    • 5.2.5. By Company (2022)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Urinalysis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. Product
    • 6.2.2. Test Type
    • 6.2.3. Application
    • 6.2.4. End user
    • 6.2.5. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Urinalysis Market Outlook.
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. Product
        • 6.3.1.2.2. Test Type
        • 6.3.1.2.3. Application
        • 6.3.1.2.4. End user
    • 6.3.2. India Urinalysis Market Outlook.
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. Product
        • 6.3.2.2.2. Test Type
        • 6.3.2.2.3. Application
        • 6.3.2.2.4. End user
    • 6.3.3. South Korea Urinalysis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. Product
        • 6.3.3.2.2. Test Type
        • 6.3.3.2.3. Application
        • 6.3.3.2.4. End user
    • 6.3.4. Japan Urinalysis Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. Product
        • 6.3.4.2.2. Test Type
        • 6.3.4.2.3. Application
        • 6.3.4.2.4. End user
    • 6.3.5. Australia Urinalysis Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. Product
        • 6.3.5.2.2. Test Type
        • 6.3.5.2.3. Application
        • 6.3.5.2.4. End user

7. Europe Urinalysis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Product
    • 7.2.2. Test Type
    • 7.2.3. Application
    • 7.2.4. End user
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Urinalysis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Product
        • 7.3.1.2.2. Test Type
        • 7.3.1.2.3. Application
        • 7.3.1.2.4. End user
    • 7.3.2. Germany Urinalysis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Product
        • 7.3.2.2.2. Test Type
        • 7.3.2.2.3. Application
        • 7.3.2.2.4. End user
    • 7.3.3. United Kingdom Urinalysis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Product
        • 7.3.3.2.2. Test Type
        • 7.3.3.2.3. Application
        • 7.3.3.2.4. End user
    • 7.3.4. Italy Urinalysis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Product
        • 7.3.4.2.2. Test Type
        • 7.3.4.2.3. Application
        • 7.3.4.2.4. End user
    • 7.3.5. Spain Urinalysis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Product
        • 7.3.5.2.2. Test Type
        • 7.3.5.2.3. Application
        • 7.3.5.2.4. End user

8. North America Urinalysis Market Outlook.

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Product
    • 8.2.2. Test Type
    • 8.2.3. Application
    • 8.2.4. End user
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Urinalysis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Product
        • 8.3.1.2.2. Test Type
        • 8.3.1.2.3. Application
        • 8.3.1.2.4. End user
    • 8.3.2. Mexico Urinalysis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Product
        • 8.3.2.2.2. Test Type
        • 8.3.2.2.3. Application
        • 8.3.2.2.4. End user
    • 8.3.3. Canada Urinalysis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Product
        • 8.3.3.2.2. Test Type
        • 8.3.3.2.3. Application
        • 8.3.3.2.4. End user

9. South America Urinalysis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Type
    • 9.2.2. Product Type
    • 9.2.3. Tissue
    • 9.2.4. End user
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Urinalysis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Product
        • 9.3.1.2.2. Test Type
        • 9.3.1.2.3. Application
        • 9.3.1.2.4. End user
    • 9.3.2. Argentina Urinalysis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Product
        • 9.3.2.2.2. Test Type
        • 9.3.2.2.3. Application
        • 9.3.2.2.4. End user
    • 9.3.3. Colombia Urinalysis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Product
        • 9.3.3.2.2. Test Type
        • 9.3.3.2.3. Application
        • 9.3.3.2.4. End user

10. Middle East and Africa Urinalysis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Product
    • 10.2.2. Test Type
    • 10.2.3. Application
    • 10.2.4. End user
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Urinalysis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Product
        • 10.3.1.2.2. Test Type
        • 10.3.1.2.3. Application
        • 10.3.1.2.4. End user
    • 10.3.2. Saudi Arabia Urinalysis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Product
        • 10.3.2.2.2. Test Type
        • 10.3.2.2.3. Application
        • 10.3.2.2.4. End user
    • 10.3.3. UAE Urinalysis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Product
        • 10.3.3.2.2. Test Type
        • 10.3.3.2.3. Application
        • 10.3.3.2.4. End user
    • 10.3.4. Kuwait Urinalysis Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. Product
        • 10.3.4.2.2. Test Type
        • 10.3.4.2.3. Application
        • 10.3.4.2.4. End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (In case of listed companies)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. F. Hoffmann-La Roche Ltd.
    • 13.6.2. Siemens Healthineers AG.
    • 13.6.3. Abbott Laboratories
    • 13.6.4. Cardinal Health Inc.
    • 13.6.5. Danaher Corporation
    • 13.6.6. Sysmex Corporation
    • 13.6.7. Quidel Corporation
    • 13.6.8. Becton, Dickinson & Company
    • 13.6.9. Bio-Rad Laboratories Inc.
    • 13.6.10. EKF Diagnostic s Holdings plc

14. Strategic Recommendations